Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Capital Expenditures (2016 - 2025)

Axogen (AXGN) has 15 years of Capital Expenditures data on record, last reported at $3.5 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 423.73% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.7 million, up 20.77%, while the annual FY2025 figure was $3.7 million, 20.77% up from the prior year.
  • Capital Expenditures reached $3.5 million in Q4 2025 per AXGN's latest filing, up from -$742000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $17.6 million in Q3 2021 and bottomed at -$19.2 million in Q4 2021.
  • Average Capital Expenditures over 5 years is $1.2 million, with a median of $917000.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: plummeted 741.13% in 2021, then soared 1263.33% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at -$19.2 million in 2021, then soared by 34.5% to -$12.6 million in 2022, then skyrocketed by 111.62% to $1.5 million in 2023, then tumbled by 54.2% to $670000.0 in 2024, then skyrocketed by 423.73% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $3.5 million in Q4 2025, -$742000.0 in Q3 2025, and $722000.0 in Q2 2025.